Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche To Tailor Tamiflu Production As Supply Is Ample To Meet Demand

This article was originally published in The Pink Sheet Daily

Executive Summary

Supply of the antiviral significantly exceeds current orders for pandemic planning, Roche reports.
Advertisement

Related Content

Tamiflu Drags On Roche’s First Quarter Sales
Tamiflu Drags On Roche’s First Quarter Sales
Roche Hedges On U.S. Launch Of Mircera With November FDA Action Date Expected
Roche Hedges On U.S. Launch Of Mircera With November FDA Action Date Expected
Tamiflu Lower Dose Capsules Clear FDA
Tamiflu Lower Dose Capsules Clear FDA
FDA Licenses First H5N1 Vaccine From Sanofi Pasteur
Roche Submits Tamiflu sNDA For Pediatric Capsules
Tamiflu Capacity To Exceed Government Pandemic Demand By 2007, Roche Says
Tamiflu Capacity To Exceed Government Pandemic Demand By 2007, Roche Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS065961

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel